Abstract
This memorandum was prepared by Daniel Steiner, General Counsel to Harvard University on behalf of the President's Office and distributed to the faculty in October, 1980. It reviews recent Harvard policy with regard to patents and technology transfer. Spurred by recombinant DNA research, at Harvard and elsewhere, benefits and pitfalls of the University's participation as a minor shareholder in a company engaged in research and development are identified. The author notes that “The memorandum has benefited from numerous discussions with members of the faculty and administration and in particular from the comments of President (Derek) Bok and Dean (Henry) Rosovsky.”
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steiner, D. Technology transfer at Harvard University. Bioethics Quarterly 2, 203–211 (1980). https://doi.org/10.1007/BF00917111
Issue Date:
DOI: https://doi.org/10.1007/BF00917111